Armistice Capital »

Genprex shares owned by Armistice Capital

Quarter-by-quarter ownership of Genprex (GNPX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Genprex

Tip: Access up to 7 years of quarterly data

All positions including Genprex held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genprex by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $411k 218k 1.89
2024-03-31 $292k 98k 2.98

More positions owned by Armistice Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Incyte Corporation (INCY)
Immunovant (IMVT)
Travere Therapeutics (TVTX)
Agios Pharmaceuticals (AGIO)
Grifols S A Sp Adr Rep B Nvt (GRFS)
Argenx Se Sponsored Adr (ARGX)
Inari Medical Ord (NARI)
Anheuser Busch Inbev Sa Sponsored Adr (BUD)
Dentsply Sirona (XRAY)
Novo-nordisk A S Adr (NVO)

View all positions for Armistice Capital

Top funds holding Genprex

UBS Group
Virtu Financial
Two Sigma Securities
HighTower Advisors
Geode Capital Management
Hrt Financial
Vanguard Group
BlackRock
Tower Research Capital
HighMark Wealth Management
Bank of America Corporation
Nemes Rush Group
Ashton Thomas Securities
Hanson McClain Advisors
Group One Trading

View all funds holding Genprex